Skip to main content
. Author manuscript; available in PMC: 2015 Jul 22.
Published in final edited form as: FEMS Immunol Med Microbiol. 2012 Dec 1;66(3):307–322. doi: 10.1111/j.1574-695X.2012.01010.x

Table 1.

Set-up of the experimental Mycoplasma agalactiae conjunctival and intramammary route infection

Groups Positive control Negative control Phase-locked mutants
Antigen M. agalactiae PG2 Pyrogen-free saline M. agalactiae Vpma phase-locked mutants: PLMU & PLMY
Inoculum 109 5 × 108 each mutant (total 109)
Volume of Inoculum 120 μL – conjunctival or 5 mL – intramammary 120 μL – conjunctival or 5 mL – intramammary 120 μL – conjunctival or 5 mL – intramammary
Animals 5 lambs – conjunctival or 5 lactating ewes – intramammary 5 lambs – conjunctival or 5 lactating ewes – intramammary 5 lambs – conjunctival or 5 lactating ewes – intramammary
Necropsy Day 20 (conjunctival) and Day 28 (intramammary) postinoculation